Nasdaq IPOs

Montrose Environmental Group, which provides a suite of environmental impact services, raised $150 million by offering 10 million shares at $15, the low end of the range of $15 to $17. At pricing, the company commands a fully diluted market value of $348 million. Montrose Environ

Scopus BioPharma, a preclinical biotech developing immuno-oncology gene therapies for cancer, filed on Wednesday with the SEC to raise up to $6 million in an initial public offering. The company originally filed in May 2020 but was ineligible for Renaissance Capital tracking

Pershing Square Tontine Holdings, a blank check company formed by Bill Ackman of Pershing Square targeting "Mature Unicorns," raised $4.0 billion by offering 200 million units at $20. Each unit consists of one share of common stock and one-ninth of a redeemable warrant, exercisab

Pershing Square Tontine Holdings, a blank check company formed by Bill Ackman of Pershing Square targeting "Mature Unicorns," raised $4.0 billion by offering 200 million units at $20. Each unit consists of one share of common stock and one-ninth of a redeemable warrant, exercisab

Pershing Square Tontine Holdings, a blank check company formed by Bill Ackman of Pershing Square targeting "Mature Unicorns," raised $4.0 billion by offering 200 million units at $20. Each unit consists of one share of common stock and one-ninth of a redeemable warrant, exercisab

Property Solutions Acquisition, a blank check company formed by Benchmark Real Estate Group targeting the real estate industry, raised $200 million by offering 20 million units at $10, in line with expectations. Each unit consists of one share of common stock and one whole w

Jamf Holding, which provides software for enterprises to remotely deploy Apple devices, raised $468 million by offering 18 million shares (75% primary) at $26, above the upwardly-revised range of $21 to $23.  Existing shareholders sold 2.0 million more shares than expected.

ARYA Sciences Acquisition III, the third healthcare-focused blank check company formed by Perceptive Advisors, filed on Tuesday with the SEC to raise up to $125 million in an initial public offering. The New York, NY-based company plans to raise $125 million by offering 12.5 mill

4D Molecular Therapeutics, which is developing targeted gene therapies for multiple diseases, withdrew its plans for an initial public offering on Tuesday. It originally filed in September 2019 with a proposed deal size of $100 million and had not amended its prospectus since the

Kismet Acquisition One, a blank check company formed by Kismet Capital Group targeting a Russian business, filed on Tuesday with the SEC to raise up to $250 million in an initial public offering. The Moscow, Russia-based company plans to raise $250 million by offering 25 million

Gores Holdings V, the fifth blank check company formed by The Gores Group, filed on Monday with the SEC to raise up to $400 million in an initial public offering. The Beverly Hills, CA-based company plans to raise $400 million by offering 40 million units at $10. Each unit consis

Pershing Square Tontine Holdings, a blank check company formed by Bill Ackman of Pershing Square targeting "Mature Unicorns," is expected to price this week. For access to exact trade dates, screening capabilities, and other features, sign up for a free trial of IPO Pro. The New

Pershing Square Tontine Holdings, a blank check company formed by Bill Ackman of Pershing Square targeting "Mature Unicorns," is expected to price this week. For access to exact trade dates, screening capabilities, and other features, sign up for a free trial of IPO Pro. The New

ACell, which makes surgical soft tissue implants for wounds and hernia repair, postponed its IPO on Monday. It had filed to raise $75 million by offering 5 million shares at a price range of $14 to $16. The Columbia, MD-based company was founded in 1999 and booked $100 million in

Jamf Holding, which provides software for enterprises to remotely deploy Apple devices, raised the proposed deal size for its upcoming IPO on Monday. The Minneapolis, MN-based company now plans to raise $352 million by offering 16 million shares (16% insider) at a price range of

iTeos Therapeutics, a Phase 1/2 immuno-oncology biotech developing therapies for various cancers, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $151 million by offering 8.9 million shares at a price range of $16 to $18. At the midpoint of t

Inozyme Pharma, a preclinical biotech developing therapies for diseases of abnormal mineralization, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the midpoint of the p

Vertex, which provides comprehensive tax software for businesses, announced terms for its IPO on Monday. The King of Prussia, PA-based company plans to raise $317 million by offering 21.2 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Vertex

Annexon, a Phase 1 biotech developing therapies for complement-mediated disorders, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the pro

Nurix Therapeutics, a preclinical biotech developing small molecule therapies for cancer, announced terms for its IPO on Monday. The San Francisco, CA-based company plans to raise $150 million by offering 8.8 million shares at a price range of $16 to $18. At the midpoint of the p